Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:16:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T19:08:26.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several key resources and links related to genetics and rare diseases have been removed, including MedlinePlus and NIH links, which may impact access to important health information.
    Difference
    4%
    Check dated 2024-11-23T05:34:45.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    New resources related to genetics, rare diseases, and drug information have been added, including links to MedlinePlus, NIH, and DailyMed, which may be of particular interest for those researching lung cancer and neuroendocrine tumors.
    Difference
    0.5%
    Check dated 2024-11-16T00:56:47.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while the previous version v2.12.1 has been removed.
    Difference
    4%
    Check dated 2024-11-08T18:56:38.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:25:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.